| Literature DB >> 24336818 |
Jon J Ramsey1, Dianna Tran2, Marco Giorgio3, Stephen M Griffey4, Amanda Koehne4, Steven T Laing4, Sandra L Taylor5, Kyoungmi Kim5, Gino A Cortopassi2, K C Kent Lloyd6, Kevork Hagopian2, Alexey A Tomilov2, Enrica Migliaccio3, Pier Giuseppe Pelicci3, Roger B McDonald7.
Abstract
The signaling molecule p66Shc is often described as a longevity protein. This conclusion is based on a single life span study that used a small number of mice. The purpose of the present studies was to measure life span in a sufficient number of mice to determine if longevity is altered in mice with decreased Shc levels (ShcKO). Studies were completed at UC Davis and the European Institute of Oncology (EIO). At UC Davis, male C57BL/6J WT and ShcKO mice were fed 5% or 40% calorie-restricted (CR) diets. In the 5% CR group, there was no difference in survival curves between genotypes. There was also no difference between genotypes in prevalence of neoplasms or other measures of end-of-life pathology. At 40% calorie restriction group, 70th percentile survival was increased in ShcKO, while there were no differences between genotypes in median or subsequent life span measures. At EIO, there was no increase in life span in ShcKO male or female mice on C57BL/6J, 129Sv, or hybrid C57BL/6J-129Sv backgrounds. These studies indicate that p66Shc is not a longevity protein. However, additional studies are needed to determine the extent to which Shc proteins may influence the onset and severity of specific age-related diseases.Entities:
Keywords: Aging; Longevity; Pathology.; Shc
Mesh:
Substances:
Year: 2013 PMID: 24336818 PMCID: PMC4172037 DOI: 10.1093/gerona/glt198
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.053